Laidlaw Capital Markets

Laidlaw Capital Markets offers our clients alternatives to highly structured financings that often paralyze a company’s capital structure. WE ARE BRAND COGNIZANT and strive to perform outreach to a broad base of Healthcare and Technology fundamental investors. Our team has extensive experience in executing transactions for both debt and equity in the private and public markets.

Our objective is to perform in a way where we cultivate long term relationships with exciting and growth oriented companies. We “roll up our sleeves” and help our clients add top tier shareholders, increase their liquidity profile and get their story out in a meaningful and thoughtful way. As you will see in our Case Studies, we are able to leverage our diverse institutional and retail network of sophisticated investors to deliver superior results across a variety of deal structures.

The Laidlaw Capital Markets Team has collaborated with organizations in developing strategies and goals on an individual company basis as well as assisting them in navigating the path to achieve their desired results. We have a demonstrated track record of providing the best funding available for companies that have work to do prior to moving upstream. As your company continues to grow and mature, the Laidlaw Capital Markets Team stays with you and will make introductions to Healthcare Centric Funds and Investment Banks. We believe you will the find the Laidlaw Capital Markets Brand to be true partner in your growth.

We would happy to provide you with Management References at many of the companies we have assisted.

  • Initial Public Offering (IPO)
  • Follow-On Offering
  • Confidentially Marketed Public Offering (CMPO)
  • Registered Direct (RD)
  • PIPE Transaction
  • Private Placement
  • Block trade

All of our offerings

2020-06-25T12:25:40-04:00


Beyond Air

Follow-On Offering
Common Stock
.

$10,500,000

Financial Advisor
December 2019

2020-06-25T12:26:45-04:00


Affimed

Follow-On Offering
Common Stock
.

$34,500,000

Co-Manager
November 2019

2018-05-14T13:55:01-04:00

MEI
Pharma

PIPE Transaction
Common Stock and Warrants
 

$75,000,000

Co-Placement Agent
May 2018

2018-05-17T20:34:24-04:00

Sesen
Bio

Registered Direct
Common Stock and
Warrants

$10,000,000

Exclusive Placement Agent
March 2018

2018-06-01T01:40:10-04:00


AIT Therapeutics

PIPE Transaction
Warrants
.

$9,820,154.54

Exclusive Placement Agent
February 2018

2018-05-04T14:37:33-04:00


Affimed

Follow-On Offering
Common Stock
 

$23,000,000

Financial Advisor
February 2018

2018-05-04T14:41:44-04:00

Cytori
Therapeutics

Rights Offering
Convertible Preferred
Stock and Warrants

$10,000,000

Financial Advisor
November 2017

2018-05-04T15:09:37-04:00

Onconova
Therapeutics

Registered Direct
Common Stock
 

$1,380,000

Sole Placement Agent
November 2017

2018-05-04T15:20:13-04:00

Repros
Therapeutics

Confidentially Marketed
Public Offering
Common Stock and Warrants

$3,000,000

Sole Book-Runner
May 2017

2018-05-04T15:27:52-04:00

Onconova
Therapeutics

Confidentially Marketed
Public Offering
Common Stock

$5,963,517

Sole Book Runner
April 2017

2018-05-04T15:34:41-04:00


BioSig Technologies

PIPE Transaction
Common Stocks
& Warrants

$4,349,954

Exclusive Placement Agent
March 2017

2018-05-04T15:28:33-04:00

Therapix
Biosciences

Initial Public Offering
Common Stock
 

$13,800,000

Sole Book Runner
March 2017

2018-05-04T15:28:47-04:00

Gemphire

PIPE Transaction
Common Stock & Warrants
 

$12,500,000

Co-Manager
March 2017

2018-05-04T15:32:10-04:00


AIT Therapeutics

PIPE Transaction,
Common Stock
and Warrants

$10,200,000

Placement Agent
March 2017

2018-05-04T15:32:33-04:00


Evoke Pharma

Confidentially Marketed
Follow-On
Common Stock

$8,050,000

Sole Book Runner
February 2017

2018-05-04T15:34:50-04:00


Medovex Corporation

PIPE Transaction
Common Stock & Warrants
 

$3,022,000

Exclusive Placement Agent
February 2017

2018-05-04T15:57:47-04:00

Medovex
Corporation

PIPE Transaction
Common Stock
& Warrants

$1,398,033

Placement Agent
April 2016

2018-05-04T15:48:50-04:00


ImmunoCellular

Follow-On Offering
Common Stocks
& Warrants

$7,400,000

Lead Manager
August 2016

2018-05-04T15:45:14-04:00


Gemphire

Initial Public Offering
Common Stock
 

$30,000,000

Co-Manager
August 2016

2018-05-04T15:46:19-04:00


PhaseRx

Initial Public Offering
Common Stock
 

$18,500,000

Book Runner
May 2016

2018-05-04T15:55:48-04:00

Aeolus
Pharmaceuticals

PIPE Transaction
Common Stock
& Warrants

$6,750,000

Exclusive Placement Agent
December 2015

2018-05-04T15:54:44-04:00


Cerecor, Inc.

Initial Public Offering
Common Stock
& Warrants

$26,000,000

Lead Manager
October 2015

2018-05-04T15:59:54-04:00

Sevion
Therapeutics

PIPE Transaction
Common Stocks
& Warrants

$7,325,217

Exclusive Placement Agent
July 2015

2018-05-04T16:00:52-04:00

Viking
Therapeutics

Initial Public Offering
Common Stock
 

$27,600,000

Sole Book-Runner
May 2015

2018-05-04T16:03:10-04:00


ADMA Biologics

Follow-On Offering
Common Stock
 

$9,800,000

Co-Manager
March 2015

2018-05-04T16:03:50-04:00

Medovex
Corporation

Initial Public Offering
Common Stock
& Warrants

$9,200,000

Sole Book-Runner
December 2014

2018-05-04T16:04:24-04:00

Cel-Sci
Corporation

Follow-On Offering
Common Stock
& Warrants

$7,000,000

Sole Book-Runner
October 2014

2018-05-04T16:05:10-04:00

Relmada
Therapeutics

 
Common Stock & Warrants
 

$28,000,000

Exclusive Placement Agent
June 2014

2018-05-04T16:05:31-04:00

Cel-Sci
Corporation

Follow-On Offering
Common Stock
& Warrants

$10,000,000

Joint Book-Runner
April 2014

2018-05-04T16:11:19-04:00

Cel-Sci
Corporation

Follow-On offering
Common Stock & Warrants
 

$3,000,000

Sole Book-runner
December 2013

2018-05-04T16:11:34-04:00


ADMA Biologics

Initial Public Offering
Common Stock
 

$28,347,500

Co-Manager
October 2013

2018-05-04T16:11:55-04:00

Cel-Sci
Corporation

Follow-On Offering
Common Stock
& Warrants

$17,826,087

Co-Manager
October 2013

2018-05-04T16:12:06-04:00

Relmada
Therapeutics

Convertible
Preferred Stock
& Warrants

$8,000,000

Placement Agent
September 2013

2018-05-04T16:12:39-04:00

Relmada
Therapeutics

Convertible Bridge
Notes & Warrants
 

$750,000

Placement Agent
September 2013

2018-05-04T16:12:58-04:00


Alliqua

Common Stock &
Warrants
 

$3,000,000

Co-Manager
July 2013